Latest prostate News | Page 4

One year of telenursing
10 years on: Reflections from survivor
New device relieves stress of urinary dysfunction
First patient dosed in Telix ‘ProstACT’ therapeutic program
Male carriers of BRCA1 and BRCA2 gene mutation also at risk of multiple cancers: study
Significant capital raise for emerging Australian company
New Year A-Team fundraising challenge set to be lifesaver
Four-wheel drive fundraiser revs up support for prostate cancer
Support for men with prostate cancer impacted by pandemic
Medicine agency recommends listing of life-saving drugs for Australian men with deadly forms of prostate cancer
Simple solutions for stress-free Christmas
Active surveillance: where are we now?
Changing face of men’s health
Bold vision to double prostate cancer funding and wipe out deaths from disease by 2040
Prostate cancer support group launched in Meekatharra
TGA approves Telix Pharmaceuticals’ Illuccix for prostate cancer
New support for prostate cancer patients
Additional support for Australian men battling prostate cancer
Find Cancer Early campaign relaunched in WA following new survey results
Tissue-engineered prostate tumours shed light on cancer spread
TGA grants priority review for Telix Pharmaceuticals’ TLX591-CDx
Noxopharm completes $23m share placement
China Grand Pharma signs A$400m commercial partnership with Telix Pharma
Cancer shifts to chronic disease, so living well matters
New findings speed progress towards affordable gene therapy
Gisborne’s Motivation for Movember
Movember challenge – Boon Squad
Houston companies awarded top honors at premier life science venture capital conference
Australian-first study on new precision prostate cancer treatment
Covid-19 won’t mask support for men’s health
Underlying design mechanism and morphology of humanized bone probed
New standard aims to reduce bill shock for cancer patients
Trial helps men with prostate cancer
CFA proudly supports Movember 2020
Australian first relieves prostate issues
Genetic risk factors identified for prostate cancer
Advanced prostate cancer has an unexpected weakness that can be targeted by drugs
Academic Awards recognize outstanding research at TU/e
Canberra pharmacist on cutting edge of men’s health treatment
COVID-19 treatment clinical trial underway
Saving question – could this be sepsis?
Hospitals Ready And Waiting To Support All Victorians
Shortage of olmesartan and prazosin tablets
Study reveals possible new coronavirus entry points
Westmead Private ‘takes surgery to next level’
USQ cancer researcher shortlisted for global cancer group
World first global review reveals health benefits of humble mushroom
Coloured hard hats to raise health awareness